Oragen Therapeutics
PrivateLast Round
Crowdfunding
Apr 16, 2026
Est. Valuation
$3.9M
Total Funding Raised
$840,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Oragen Therapeutics is a biotechnology company that develops an oral nucleic acid delivery platform for the treatment of inflammatory bowel diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Oragen Therapeutics Comparables
Compare Oragen Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Particella | 78% | |
| Thalia Therapeutics PLC | 66% | |
| Biora Therapeutics | 63% |
Oragen Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Crowdfunding | Apr 16, 2026 |
Key People
Founding team and executive leadership
Oragen Therapeutics Investors
Notable investors and investment history
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 547% MoM, from 180 to 1.2K.
Oragen Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Oragen Therapeutics's valuation, stock price, and market status.
Is Oragen Therapeutics a public or private company?
Oragen Therapeutics is a private company.
What is the current stock price of Oragen Therapeutics?
Oragen Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Oragen Therapeutics worth (valuation)?
Oragen Therapeutics's valuation is estimated at $3.9M based on funding round data.
Can I buy Oragen Therapeutics stock?
Oragen Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Oragen Therapeutics's last funding round?
Oragen Therapeutics's most recent funding round was Crowdfunding on April 16, 2026.
Who are the main investors in Oragen Therapeutics?
Key investors in Oragen Therapeutics include SAYENS, DECA-BFC.
Will Oragen Therapeutics IPO soon?
No public IPO plans have been announced for Oragen Therapeutics.
How can I track Oragen Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Oragen Therapeutics's secondary market activity and sign up for updates.